Connacht Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,238
| Closed | -$236K | – | 55 |
|
|
2023
Q2 | $236K | Buy |
7,238
+364
| +5% | +$11.9K | 0.32% | 59 |
|
|
2023
Q1 | $242K | Buy |
6,874
+374
| +6% | +$13.2K | 0.1% | 68 |
|
|
2022
Q4 | $298K | Buy |
6,500
+796
| +14% | +$36.5K | 0.13% | 65 |
|
|
2022
Q3 | $276K | Buy |
5,704
+89
| +2% | +$4.31K | 0.2% | 68 |
|
|
2022
Q2 | $221K | Sell |
5,615
-1,775
| -24% | -$69.9K | 0.09% | 83 |
|
|
2022
Q1 | $272K | Sell |
7,390
-4,627
| -39% | -$170K | 0.14% | 80 |
|
|
2021
Q4 | $548K | Buy |
+12,017
| New | +$548K | 0.53% | 56 |
|